Inactive Instrument

Press Releases Champignon Brands Canadian Securities Exchange

Equities

SHRM

CA15850D1006

Press Releases

Unlock all the news: Be the first to know and act before the market!

Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	07-15	NE
Braxia Scientific Reports Q3 2024 Financial Results	02-29	NE
Braxia Scientific Reports Mandatory Conversion of Debentures	01-15	NE
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update	11-30	NE
Braxia Scientific : Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic	01/08/23	PU
Braxia Scientific : Reports Fiscal 2023 Financial Results	01/08/23	PU
Irwin Naturals Inc.: Update on LOI for Business Combination with Braxia Scientific Corp.	21/03/23	AQ
Update on LOI for Business Combination with Braxia Scientific Corp.	20/03/23	AQ
Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics	20/02/23	AQ
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals	07/02/23	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	30/01/23	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	27/01/23	AQ
Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US	10/01/23	AQ
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America	29/11/22	AQ
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers	04/10/22	AQ
Braxia Scientific Announces Board Appointment	22/09/22	AQ
Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022	09/09/22	AQ
Braxia Scientific Reports Q1 2023 Financial Results, Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients	30/08/22	AQ
Braxia Scientific Enters U.S. Telemedicine Industry, Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	04/08/22	AQ
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	03/08/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Champignon Brands Canadian Securities Exchange

Equities

SHRM

CA15850D1006

Press Releases

Filters